{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:29:53Z","timestamp":1791804593940,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T00:00:00Z","timestamp":1355097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T00:00:00Z","timestamp":1355097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/bmt.2012.239","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T11:45:03Z","timestamp":1355139903000},"page":"537-543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":247,"title":["Graft failure in the modern era of allogeneic hematopoietic SCT"],"prefix":"10.1038","volume":"48","author":[{"given":"R","family":"Olsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Remberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D M","family":"Berggren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B-M","family":"Svahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Ringden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,10]]},"reference":[{"key":"BFbmt2012239_CR1","doi-asserted-by":"publisher","first-page":"E68","DOI":"10.1111\/j.1399-0012.2010.01324.x","volume":"25","author":"M Remberger","year":"2011","unstructured":"Remberger M, Mattsson J, Olsson R, Ringden O . Second allogeneic hematopoietic stem cell transplantation (HSCT): a treatment for graft failure. Clin Transplant 2011; 25: E68\u2013E76.","journal-title":"Clin Transplant"},{"key":"BFbmt2012239_CR2","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.bbmt.2010.02.013","volume":"16","author":"J Schriber","year":"2010","unstructured":"Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, Lazarus HM et al. Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Bone Marrow Transplant 2010; 16: 1099\u20131106.","journal-title":"Biol Blood Bone Marrow Transplant"},{"issue":"Supplement 1","key":"BFbmt2012239_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbmt.2007.10.025","volume":"14","author":"J Mattsson","year":"2008","unstructured":"Mattsson J, Ringden O, Storb R . Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008; 14 (Supplement 1): 165\u2013170.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012239_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/bmt.2009.67","volume":"44","author":"R Crocchiolo","year":"2009","unstructured":"Crocchiolo R, Ciceri F, Fleischhauer K, Oneto R, Bruno B, Pollichieni S et al. [HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry]. Bone Marrow Transplant 2009; 44: 571\u2013577.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012239_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.bbmt.2007.01.084","volume":"13","author":"M Remberger","year":"2007","unstructured":"Remberger M, Watz E, Ringden O, Mattsson J, Shanwell A, Wikman A . Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 675\u2013682.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012239_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1084\/jem.134.1.83","volume":"134","author":"G Cudkowicz","year":"1971","unstructured":"Cudkowicz G, Bennett M . Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med 1971; 134: 83\u2013102.","journal-title":"J Exp Med"},{"key":"BFbmt2012239_CR7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/eji.1830070915","volume":"7","author":"R Kiessling","year":"1977","unstructured":"Kiessling R, Hochman PS, Haller O, Shearer GM, Wigzell H, Cudkowicz G . Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol 1977; 7: 655\u2013663.","journal-title":"Eur J Immunol"},{"key":"BFbmt2012239_CR8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1084\/jem.166.5.1499","volume":"166","author":"WJ Murphy","year":"1987","unstructured":"Murphy WJ, Kumar V, Bennett M . Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med 1987; 166: 1499\u20131509.","journal-title":"J Exp Med"},{"key":"BFbmt2012239_CR9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood.V68.4.861.861","volume":"68","author":"RF Raff","year":"1986","unstructured":"Raff RF, Deeg HJ, Loughran TP, Graham TC, Aprile JA, Sale GE et al. Characterization of host cells involved in resistance to marrow grafts in dogs transplanted from unrelated DLA-nonidentical donors. Blood 1986; 68: 861\u2013868.","journal-title":"Blood"},{"key":"BFbmt2012239_CR10","first-page":"893","volume":"22","author":"RF Raff","year":"1994","unstructured":"Raff RF, Sandmaier BM, Graham T, Loughran TP, Pettinger M, Storb R . \u2018Resistance\u2019 to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex. Exp Hematol 1994; 22: 893\u2013897.","journal-title":"Exp Hematol"},{"key":"BFbmt2012239_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/00007890-198709000-00003","volume":"44","author":"HJ Deeg","year":"1987","unstructured":"Deeg HJ, Sale GE, Storb R, Graham TC, Schuening F, Appelbaum FR et al. Engraftment of DLA-nonidentical bone marrow facilitated by recipient treatment with anti-class II monoclonal antibody and methotrexate. Transplantation 1987; 44: 340\u2013345.","journal-title":"Transplantation"},{"key":"BFbmt2012239_CR12","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1182\/blood.V74.5.1477.1477","volume":"74","author":"AJ Barge","year":"1989","unstructured":"Barge AJ, Johnson G, Witherspoon R, Torok-Storb B . Antibody-mediated marrow failure after allogeneic bone marrow transplantation. Blood 1989; 74: 1477\u20131480.","journal-title":"Blood"},{"key":"BFbmt2012239_CR13","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1126\/science.147.3660.873","volume":"147","author":"E Moeller","year":"1965","unstructured":"Moeller E . Contact-induced cytotoxicity by lymphoid cells containing foreign isoantigens. Science 1965; 147: 873\u2013879.","journal-title":"Science"},{"key":"BFbmt2012239_CR14","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.4049\/jimmunol.112.4.1508","volume":"112","author":"R Storb","year":"1974","unstructured":"Storb R, Floersheim GL, Weiden PL, Graham TC, Kolb HJ, Lerner KG et al. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum. J Immunol 1974; 112: 1508\u20131516.","journal-title":"J Immunol"},{"key":"BFbmt2012239_CR15","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1182\/blood-2006-05-022772","volume":"109","author":"PA Taylor","year":"2007","unstructured":"Taylor PA, Ehrhardt MJ, Roforth MM, Swedin JM, Panoskaltsis-Mortari A, Serody JS et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood 2007; 109: 1307\u20131315.","journal-title":"Blood"},{"issue":"1 Part 1","key":"BFbmt2012239_CR16","first-page":"245","volume":"13","author":"RP Warren","year":"1981","unstructured":"Warren RP, Storb R, Weiden PL, Su PJ, Thomas ED . Lymphocyte-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity in patients with aplastic anemia: distinguishing transfusion-induced sensitization from possible immune-mediated aplastic anemia. Transplant Proc 1981; 13 (1 Part 1): 245\u2013247.","journal-title":"Transplant Proc"},{"key":"BFbmt2012239_CR17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/TP.0b013e3181820333","volume":"86","author":"A Nordlander","year":"2008","unstructured":"Nordlander A, Mattsson J, Sundberg B, Sumitran-Holgersson S . Novel antibodies to the donor stem cell population CD34+\/VEGFR-2+ are associated with rejection after hematopoietic stem cell transplantation. Transplantation 2008; 86: 686\u2013696.","journal-title":"Transplantation"},{"key":"BFbmt2012239_CR18","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V83.9.2723.2723","volume":"83","author":"O Ringden","year":"1994","unstructured":"Ringden O, Ruutu T, Remberger M, Nikoskelainen J, Volin L, Vindelov L et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 1994; 83: 2723\u20132730.","journal-title":"Blood"},{"key":"BFbmt2012239_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/BF02906128","volume":"16","author":"M Hassan","year":"1999","unstructured":"Hassan M . The role of busulfan in bone marrow transplantation. Med Oncol 1999; 16: 166\u2013176.","journal-title":"Med Oncol"},{"key":"BFbmt2012239_CR20","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","volume":"101","author":"D Niederwieser","year":"2003","unstructured":"Niederwieser D, Maris M, Shizuru JA, Petersdorf E, Hegenbart U, Sandmaier BM et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003; 101: 1620\u20131629.","journal-title":"Blood"},{"key":"BFbmt2012239_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/sj.bmt.1703811","volume":"31","author":"P Hentschke","year":"2003","unstructured":"Hentschke P, Barkholt L, Uzunel M, Mattsson J, Wersall P, Pisa P et al. Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma. Bone Marrow Transplant 2003; 31: 253\u2013261.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012239_CR22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756\u2013763.","journal-title":"Blood"},{"key":"BFbmt2012239_CR23","first-page":"619","volume":"15","author":"O Ringden","year":"1995","unstructured":"Ringden O, Remberger M, Persson U, Ljungman P, Aldener A, Andstrom E et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995; 15: 619\u2013625.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012239_CR24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.V71.2.293.293","volume":"71","author":"R Storb","year":"1988","unstructured":"Storb R, Deeg HJ, Fisher L, Appelbaum F, Buckner CD, Bensinger W et al. Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials. Blood 1988; 71: 293\u2013298.","journal-title":"Blood"},{"key":"BFbmt2012239_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/bmt.2008.239","volume":"42","author":"O Ringden","year":"2008","unstructured":"Ringden O, Okas M, Uhlin M, Uzunel M, Remberger M, Mattsson J . Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor. Bone Marrow Transplant 2008; 42: 643\u2013648.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012239_CR26","first-page":"221","volume":"7","author":"O Ringden","year":"1991","unstructured":"Ringden O, Pihlstedt P, Markling L, Aschan J, Baryd I, Ljungman P et al. Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplant 1991; 7: 221\u2013226.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012239_CR27","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1182\/blood.V88.9.3634.bloodjournal8893634","volume":"88","author":"RA Nash","year":"1996","unstructured":"Nash RA, Pineiro LA, Storb R, Deeg HJ, Fitzsimmons WE, Furlong T et al. FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood 1996; 88: 3634\u20133641.","journal-title":"Blood"},{"key":"BFbmt2012239_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbmt.2003.12.305","volume":"10","author":"C Cutler","year":"2004","unstructured":"Cutler C, Kim HT, Hochberg E, Ho V, Alyea E, Lee SJ et al. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 328\u2013336.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012239_CR29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.TP.0000133513.29923.44","volume":"78","author":"M Remberger","year":"2004","unstructured":"Remberger M, Svahn BM, Mattsson J, Ringden O . Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation. Transplantation 2004; 78: 122\u2013127.","journal-title":"Transplantation"},{"key":"BFbmt2012239_CR30","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1182\/blood-2002-03-0801","volume":"100","author":"BM Svahn","year":"2002","unstructured":"Svahn BM, Remberger M, Myrback KE, Holmberg K, Eriksson B, Hentschke P et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 2002; 100: 4317\u20134324.","journal-title":"Blood"},{"key":"BFbmt2012239_CR31","first-page":"137","volume":"47","author":"G Lundgren","year":"1985","unstructured":"Lundgren G, Wilczek H, Lonnqvist B, Lindholm A, Wahren B, Ringden O . Acyclovir prophylaxis in bone marrow transplant recipients. Scand J Infect Dis Suppl 1985; 47: 137\u2013144.","journal-title":"Scand J Infect Dis Suppl"},{"key":"BFbmt2012239_CR32","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","volume":"100","author":"T Ruutu","year":"2002","unstructured":"Ruutu T, Eriksson B, Remes K, Juvonen E, Volin L, Remberger M et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 2002; 100: 1977\u20131983.","journal-title":"Blood"},{"key":"BFbmt2012239_CR33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bmt.1704108","volume":"32","author":"M Remberger","year":"2003","unstructured":"Remberger M, Naseh N, Aschan J, Barkholt L, LeBlanc K, Svennberg P et al. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV. Bone Marrow Transplant 2003; 32: 217\u2013223.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012239_CR34","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/TP.0b013e3181f585c7","volume":"90","author":"O Ringden","year":"2010","unstructured":"Ringden O, Hassan Z, Karlsson H, Olsson R, Omazic B, Mattsson J et al. Granulocyte colony-stimulating factor induced acute and chronic graft-versus-host disease. Transplantation 2010; 90: 1022\u20131029.","journal-title":"Transplantation"},{"key":"BFbmt2012239_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.bmt.1701290","volume":"22","author":"M Remberger","year":"1998","unstructured":"Remberger M, Ringden O, Ljungman P, Hagglund H, Winiarski J, Lonnqvist B et al. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 22: 73\u201378.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012239_CR36","first-page":"801","volume":"88","author":"M Barrios","year":"2003","unstructured":"Barrios M, Jimenez-Velasco A, Roman-Gomez J, Madrigal ME, Castillejo JA, Torres A et al. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia. Haematologica 2003; 88: 801\u2013810.","journal-title":"Haematologica"},{"key":"BFbmt2012239_CR37","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1182\/blood.V99.12.4618","volume":"99","author":"M Alizadeh","year":"2002","unstructured":"Alizadeh M, Bernard M, Danic B, Dauriac C, Birebent B, Lapart C et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002; 99: 4618\u20134625.","journal-title":"Blood"},{"key":"BFbmt2012239_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1469-8749.2007.00693.x","volume":"49","author":"T Lucke","year":"2007","unstructured":"Lucke T, Das AM, Hartmann H, Sykora KW, Donnerstag F, Schmid-Ott G et al. Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study. Dev Med Child Neurol 2007; 49: 693\u2013696.","journal-title":"Dev Med Child Neurol"},{"key":"BFbmt2012239_CR39","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1182\/blood-2006-07-036657","volume":"109","author":"JE Wagner","year":"2007","unstructured":"Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007; 109: 2256\u20132262.","journal-title":"Blood"},{"key":"BFbmt2012239_CR40","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/bmt.2010.227","volume":"46","author":"L Castagna","year":"2011","unstructured":"Castagna L, Furst S, Marchetti N, El Cheikh J, Faucher C, Mohty M et al. Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT. Bone Marrow Transplant 2011; 46: 1000\u20131005.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012239_CR41","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M, van Besien K, Rondon G, Anderlini P et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531\u20134536.","journal-title":"Blood"},{"key":"BFbmt2012239_CR42","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.bbmt.2011.04.013","volume":"17","author":"CG Brunstein","year":"2011","unstructured":"Brunstein CG, Noreen H, DeFor TE, Maurer D, Miller JS, Wagner JE . Anti-HLA antibodies in double umbilical cord blood transplantation. Biol Blood Marrow Transplant 2011; 17: 1704\u20131708.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012239_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1365-2141.2009.07883.x","volume":"147","author":"V Rocha","year":"2009","unstructured":"Rocha V, Gluckman E . Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br J Haematol 2009; 147: 262\u2013274.","journal-title":"Br J Haematol"},{"key":"BFbmt2012239_CR44","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.bbmt.2011.01.012","volume":"17","author":"A Ruggeri","year":"2011","unstructured":"Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J et al. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant 2011; 17: 1375\u20131382.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012239_CR45","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1182\/blood.V92.10.3515","volume":"92","author":"EW Petersdorf","year":"1998","unstructured":"Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Mickelson EM et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92: 3515\u20133520.","journal-title":"Blood"},{"key":"BFbmt2012239_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbmt.2003.10.001","volume":"10","author":"O Ringden","year":"2004","unstructured":"Ringden O, Schaffer M, Le Blanc K, Persson U, Hauzenberger D, Abedi MR et al. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers? Biol Blood Marrow Transplant 2004; 10: 128\u2013134.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012239_CR47","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1182\/blood.V99.11.4200","volume":"99","author":"Y Morishima","year":"2002","unstructured":"Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002; 99: 4200\u20134206.","journal-title":"Blood"},{"key":"BFbmt2012239_CR48","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/jama.1983.03330330044034","volume":"249","author":"MM Bortin","year":"1983","unstructured":"Bortin MM, Gale RP, Kay HE, Rimm AA . Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality. Jama 1983; 249: 1166\u20131175.","journal-title":"Jama"},{"key":"BFbmt2012239_CR49","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1046\/j.1365-2141.2003.04364.x","volume":"121","author":"O Ringden","year":"2003","unstructured":"Ringden O, Barrett AJ, Zhang MJ, Loberiza FR, Bolwell BJ, Cairo MS et al. Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. Br J Haematol 2003; 121: 874\u2013885.","journal-title":"Br J Haematol"},{"key":"BFbmt2012239_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00007890-198507000-00009","volume":"40","author":"O Ringden","year":"1985","unstructured":"Ringden O, Nilsson B . Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy. Transplantation 1985; 40: 39\u201344.","journal-title":"Transplantation"},{"key":"BFbmt2012239_CR51","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V89.11.4226","volume":"89","author":"J Sierra","year":"1997","unstructured":"Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 1997; 89: 4226\u20134235.","journal-title":"Blood"},{"key":"BFbmt2012239_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1056\/NEJM197701132960201","volume":"296","author":"R Storb","year":"1977","unstructured":"Storb R, Prentice RL, Thomas ED . Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 1977; 296: 61\u201366.","journal-title":"N Engl J Med"},{"key":"BFbmt2012239_CR53","first-page":"635","volume":"4","author":"J Tollemar","year":"1989","unstructured":"Tollemar J, Ringden O, Bostrom L, Nilsson B, Sundberg B . Variables predicting deep fungal infections in bone marrow transplant recipients. Bone Marrow Transplant 1989; 4: 635\u2013641.","journal-title":"Bone Marrow Transplant"},{"issue":"1 Part 3","key":"BFbmt2012239_CR54","first-page":"2608","volume":"19","author":"R Storb","year":"1987","unstructured":"Storb R, Deeg HJ, Whitehead J, Farewell V, Appelbaum FR, Beatty P et al. Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease. Transplant Proc 1987; 19 (1 Part 3): 2608\u20132613.","journal-title":"Transplant Proc"},{"key":"BFbmt2012239_CR55","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1097\/01.TP.0000129809.09718.7E","volume":"78","author":"K Le Blanc","year":"2004","unstructured":"Le Blanc K, Remberger M, Uzunel M, Mattsson J, Barkholt L, Ringden O . A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation. Transplantation 2004; 78: 1014\u20131020.","journal-title":"Transplantation"},{"key":"BFbmt2012239_CR56","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1182\/blood-2010-11-317271","volume":"118","author":"CE Stevens","year":"2011","unstructured":"Stevens CE, Carrier C, Carpenter C, Sung D, Scaradavou A . HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection. Blood 2011; 118: 3969\u20133978.","journal-title":"Blood"},{"key":"BFbmt2012239_CR57","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","volume":"78","author":"AM Marmont","year":"1991","unstructured":"Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120\u20132130.","journal-title":"Blood"},{"key":"BFbmt2012239_CR58","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1200\/JCO.2000.18.11.2269","volume":"18","author":"MR Bishop","year":"2000","unstructured":"Bishop MR, Tarantolo SR, Pavletic ZS, Lynch JC, Morris ME, Zacharias D et al. Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantation. J Clin Oncol 2000; 18: 2269\u20132272.","journal-title":"J Clin Oncol"},{"key":"BFbmt2012239_CR59","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","volume":"76","author":"HJ Kolb","year":"1990","unstructured":"Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462\u20132465.","journal-title":"Blood"},{"key":"BFbmt2012239_CR60","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1089\/scd.2009.1809.edi","volume":"18","author":"O Ringden","year":"2009","unstructured":"Ringden O . Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation. Stem Cells Dev 2009; 18: 1243\u20131246.","journal-title":"Stem Cells Dev"},{"key":"BFbmt2012239_CR61","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1089\/scd.2009.0029","volume":"18","author":"N Meuleman","year":"2009","unstructured":"Meuleman N, Tondreau T, Ahmad I, Kwan J, Crokaert F, Delforge A et al. Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study. Stem Cells Dev 2009; 18: 1247\u20131252.","journal-title":"Stem Cells Dev"}],"updated-by":[{"DOI":"10.1038\/bmt.2013.32","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T00:00:00Z","timestamp":1364947200000}}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2012239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012239","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T17:43:56Z","timestamp":1687887836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2012239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,10]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["BFbmt2012239"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2012.239","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,10]]},"assertion":[{"value":"2 February 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}